CRIS Current Research Information System

GUGLIELMO, ALBA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.067
NA - Nord America 1.542
EU - Europa 1.076
SA - Sud America 102
AF - Africa 99
OC - Oceania 2
Totale 4.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.510
VN - Vietnam 557
SG - Singapore 548
CN - Cina 483
IT - Italia 342
SE - Svezia 154
DE - Germania 137
HK - Hong Kong 136
GB - Regno Unito 93
IN - India 82
KR - Corea 74
BR - Brasile 70
NL - Olanda 57
RU - Federazione Russa 50
FR - Francia 48
BD - Bangladesh 46
IE - Irlanda 41
AT - Austria 33
CI - Costa d'Avorio 33
ZA - Sudafrica 29
JP - Giappone 28
FI - Finlandia 25
AR - Argentina 20
CA - Canada 17
ID - Indonesia 16
TG - Togo 16
BG - Bulgaria 15
PH - Filippine 15
CH - Svizzera 14
JO - Giordania 13
ES - Italia 11
MX - Messico 11
PL - Polonia 11
TR - Turchia 11
IQ - Iraq 10
TH - Thailandia 9
UA - Ucraina 9
HR - Croazia 8
PK - Pakistan 7
SC - Seychelles 7
TW - Taiwan 7
EC - Ecuador 6
LT - Lituania 6
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
UZ - Uzbekistan 4
DK - Danimarca 3
IR - Iran 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
IL - Israele 2
MA - Marocco 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 4.888
Salva come PNG Salva come JPEG
Città #
Singapore 388
Ashburn 181
Chandler 173
Hefei 164
San Jose 148
Ho Chi Minh City 137
Hong Kong 128
Hanoi 112
Santa Clara 93
Bologna 77
Dong Ket 74
Southend 69
Seoul 66
Fairfield 55
Beijing 54
Boardman 44
Dublin 41
Los Angeles 41
Princeton 40
New York 38
Abidjan 33
Houston 32
Dallas 31
Council Bluffs 30
Vienna 30
Milan 29
Lauterbourg 28
Tokyo 25
Redmond 24
Wilmington 24
Johannesburg 22
Haiphong 20
Seattle 19
Rome 18
Munich 17
Da Nang 16
Lomé 16
Turin 16
Woodbridge 16
Cambridge 15
Helsinki 15
Sofia 15
Bengaluru 14
Frankfurt am Main 14
Amman 13
Berlin 13
Buffalo 13
Des Moines 12
Redondo Beach 12
Ann Arbor 11
Bremen 11
Verona 11
Bern 9
Florence 9
Jakarta 9
Phoenix 9
São Paulo 9
Quận Bình Thạnh 8
San Diego 8
Warsaw 8
Delhi 7
Kuban 7
London 7
Nuremberg 7
Piacenza 7
Toronto 7
Amsterdam 6
Biên Hòa 6
Guangzhou 6
Turku 6
Abeokuta 5
Bắc Giang 5
Bắc Ninh 5
Genoa 5
Hyderabad 5
Hải Dương 5
Nanjing 5
Pune 5
Redwood City 5
San Francisco 5
Taranto 5
Thái Nguyên 5
Yubileyny 5
Atlanta 4
Bangkok 4
Bari 4
Can Tho 4
Catania 4
Chicago 4
Chongqing 4
Hangzhou 4
Jinan 4
Lappeenranta 4
Manchester 4
Mexico City 4
Montreal 4
Naples 4
The Dalles 4
Thái Bình 4
Tongling 4
Totale 3.006
Salva come PNG Salva come JPEG
Nome #
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 240
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 222
Herpes zoster in COVID-19-positive patients 207
Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls 193
Cutaneous squamous cell carcinoma progression during imiquimod treatment 179
PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis 175
Cutaneous adverse-events in patients treated with Ibrutinib 167
Chilblain lesions after COVID-19 mRNA vaccine 164
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 162
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 158
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 156
New insights into alopecia areata during COVID-19 pandemic: When infection or vaccination could play a role 156
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 156
Biological therapy in patients with psoriasis: What we know about the effects on renal function 154
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 153
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid 136
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 135
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 134
Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown 125
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients 125
Terra firma-forme dermatosis: a systematic review 124
Generalized granuloma annulare-like eruption secondary to acute Epstein–Barr virus infection 118
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 111
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals 106
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 101
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 100
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 98
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 96
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 87
'Colouring' wipes phenomenon: a peculiar skin pigmentation induced by ascorbic acid observed during lockdown 85
The red half-moon nail sign: a novel manifestation of coronavirus infection. 76
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives 74
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 68
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge 58
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 57
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? 57
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective study 53
Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes 51
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 48
Interleukin‐13 inhibition and cancer risk: reply to Tang and Chen 44
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterization. 42
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review 37
Oral pigmentation in children: a diagnostic challenge 32
Totale 5.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 0 0 0 0 0 0 0 0 77
2021/2022471 43 9 20 57 32 20 7 44 28 38 109 64
2022/2023590 48 78 44 77 54 61 23 48 79 17 37 24
2023/2024215 14 40 16 27 18 49 7 16 2 6 1 19
2024/2025944 34 114 79 89 118 35 80 44 7 69 76 199
2025/20262.496 213 301 195 160 229 122 169 120 510 227 154 96
Totale 5.020